HomeBREAKING NEWS Bharat Biotech Submits Phase-1 Trial Data of ‘Game Changer’ Intranasal Covid Vaccine June 23, 2021 Share Facebook Twitter Pinterest WhatsApp The company sought permission from the drug regulator for a change from nasal drop to spray; expert panel advised both drop and spray be used for clinical trials. Previous articleMonsoon Rain Exposes Shoddy Quality of Pithoragarh’s All-Weather RoadNext articleGUJCET 2021 application released at gseb.org for details; last date to apply is 30 June Similar Articles Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims BREAKING NEWS - October 5, 2021 The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay... Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms BREAKING NEWS - October 5, 2021 A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths... Most Popular AMPC reforms: BJP digs out Siddaramaiah’s old letter India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films